Pitfalls and strategies of CAR-T therapy in solid tumors and implications for chordoma treatment

Area of Science:

• Immunotherapy
• Oncology
• Cellular Therapy

Background:

• Chimeric antigen receptor T-cell (CAR-T) therapy is effective for blood cancers.
• Solid tumors present unique challenges, including immunosuppressive microenvironments, hindering CAR-T efficacy.
• Chordoma, a rare bone tumor, exemplifies these challenges due to its complex tumor microenvironment.

Purpose of the Study:

• To review challenges in applying CAR-T therapy to solid tumors.
• To explore strategies for enhancing CAR-T cell function and persistence in solid tumors.
• To assess the therapeutic potential of CAR-T therapy for chordoma.

Main Methods:

• Literature review of CAR-T therapy in solid tumors.
• Analysis of the immunosuppressive tumor microenvironment.
• Identification of strategies to overcome resistance and improve CAR-T cell activity.

Main Results:

• Solid tumor microenvironments impede CAR-T cell infiltration, activity, and persistence.
• Key challenges include dense extracellular matrix and immunosuppressive factors like TGF-β.
• Strategies focus on optimizing CAR-T cells for tumor microenvironment penetration and function.

Conclusions:

• CAR-T therapy holds potential for solid tumors, but requires overcoming significant microenvironmental barriers.
• Targeting chordoma with CAR-T therapy necessitates addressing antigen scarcity and immune suppression.
• Further research into novel CAR-T engineering strategies is crucial for solid tumor treatment.